Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic
manifestations. Patients with HCV may develop mixed cryoglobulinemia and its sequelae …

Hepatitis C virus (HCV) has been shown to affect many tissues other than liver. However, of
the many extrahepatic manifestations (EMs) that have been associated with HCV, including …

Clinical trials have unequivocally shown that inhibition of proprotein convertase
subtilisin/kexin type 9 (PCSK9) efficaciously and safely prevents cardiovascular events by …

Hepatitis C virus (HCV) infection remains a major public health issue with high prevalence in
Taiwan. Recently, the advent of direct-acting antiviral (DAA) agents, with higher efficacy …

Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic
hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Hepatitis C infection associates …

Background Chronic hepatitis C (HCV) infection is associated with diabetes and favourable
lipids. Objective To study the effect of this paradox on atherosclerosis and cardiometabolic …

Background/Aims Chronic hepatitis C (CHC) patients who failed antiviral therapy are at
increased risk for hepatocellular carcinoma (HCC). This study assessed the potential role of …

Human PCSK9 is known to enhance the degradation of membrane-bound receptors such as
the hepatocyte low-density lipoprotein receptor (LDLR), ApoER2, and very low-density …

Background Metabolic abnormalities are common in HIV-infected individuals on
antiretroviral therapy (ART), but the biochemical details and underlying mechanisms of …

Hepatitis C virus (HCV) is a leading cause of chronic liver disease. The identification and
characterization of key host cellular factors that play a role in the HCV replication cycle are …